News | December 22, 2023
JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
His most recent stint was with Danone India as its Managing Director
Darunavir is a protease inhibitor antiviral medicine that prevents Human Immunodeficiency Virus (HIV-1) from multiplying in the body
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
Demonstrate significant bleed reduction in hemophilia A and B
Subscribe To Our Newsletter & Stay Updated
